| Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review KJ Siefried, LS Acheson, N Lintzeris, N Ezard CNS drugs 34 (4), 337-365, 2020 | 155 | 2020 |
| Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder TM Gates, LA Cysique, KJ Siefried, J Chaganti, KJ Moffat, BJ Brew Aids 30 (4), 591-600, 2016 | 116 | 2016 |
| Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy KJ Siefried, L Mao, LA Cysique, J Rule, ML Giles, DE Smith, J McMahon, ... Aids 32 (1), 35-48, 2018 | 73 | 2018 |
| Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression KJ Siefried, L Mao, S Kerr, LA Cysique, TM Gates, J McAllister, A Maynard, ... PLoS One 12 (4), e0174613, 2017 | 54 | 2017 |
| Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials LS Acheson, BH Williams, M Farrell, R McKetin, N Ezard, KJ Siefried Drug and Alcohol Review 42 (1), 7-19, 2023 | 23 | 2023 |
| Correlates of higher‐risk drug‐related behaviours at music festivals in New South Wales, Australia A Healey, KJ Siefried, ME Harrod, E Franklin, A Peacock, MJ Barratt, ... Drug and Alcohol Review 41 (2), 320-329, 2022 | 22 | 2022 |
| Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019–2020 J Brett, KJ Siefried, A Healey, ME Harrod, E Franklin, MJ Barratt, J Masters, ... Clinical Toxicology 60 (4), 440-445, 2022 | 18 | 2022 |
| Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study N Ezard, B Clifford, A Dunlop, R Bruno, A Carr, Z Liu, KJ Siefried, ... BMJ open 11 (5), e044696, 2021 | 16 | 2021 |
| Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not HL Aung, KJ Siefried, TM Gates, BJ Brew, L Mao, A Carr, LA Cysique EClinicalMedicine 56, 2023 | 14 | 2023 |
| Is the HIV Dementia Scale a reliable tool for assessing HIV-related neurocognitive decline GM Lu, BJ Brew, KJ Siefried, B Draper, LA Cysique J AIDS Clin Res 5 (1000269), 10.4172, 2013 | 14 | 2013 |
| Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: a pilot feasibility and safety trial LS Acheson, N Ezard, N Lintzeris, A Dunlop, J Brett, C Rodgers, A Gill, ... Drug and Alcohol Dependence 241, 109692, 2022 | 10 | 2022 |
| Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials H Sharafi, H Bakouni, C McAnulty, S Drouin, S Coronado‐Montoya, ... Addiction 119 (2), 211-224, 2024 | 7 | 2024 |
| “There’sa big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia B Clifford, K Van Gordon, F Magee, V Malone, KJ Siefried, D Graham, ... BMC health services research 23 (1), 162, 2023 | 7 | 2023 |
| Barriers to help‐seeking among music festival attendees in New South Wales, Australia R Page, A Healey, KJ Siefried, ME Harrod, E Franklin, A Peacock, ... Drug and alcohol review 41 (6), 1322-1330, 2022 | 7 | 2022 |
| A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia KJ Siefried, N Ezard, M Christmass, P Haber, R Ali, ... Drug and Alcohol Review 41 (2), 309-319, 2022 | 7 | 2022 |
| Controlling for pleasure and risk: The experiences of sexuality and gender diverse people who use GHB J Freestone, G Prestage, A Bourne, N Ezard, K Race, A Nedanoski, ... International Journal of Drug Policy 105, 103747, 2022 | 6 | 2022 |
| Phenobarbital to manage severe gamma‐hydroxybutyrate withdrawal: A case series G Freeman, KJ Siefried, DM Roberts, C Rodgers, U Nic Ionmhain, ... Drug and Alcohol Review 42 (1), 27-32, 2023 | 5 | 2023 |
| Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal LS Acheson, N Ezard, N Lintzeris, A Dunlop, J Brett, C Rodgers, A Gill, ... Plos one 17 (10), e0275371, 2022 | 5 | 2022 |
| PAART study investigators Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy KJ Siefried, L Mao, LA Cysique, J Rule, ML Giles, DE Smith, J McMahon, ... Aids 32 (1), 35-48, 2018 | 5 | 2018 |
| Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review KJ Siefried, G Freeman, DM Roberts, R Lindsey, C Rodgers, N Ezard, ... Psychopharmacology 240 (1), 127-135, 2023 | 4 | 2023 |
